Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576940.RAAeNSM38gGkgGCl-T20dtJ5BDz3Pz0DqUuC1lbjCq3dU130_provenance.
• NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP407891.RARUeGwVkfmUnKP6-evLLX6TgipVbTGXlLelYRCtcEjIU130_provenance.
• NP408184.RA-B-CVJdvz9q6ojR6bX7qSXHTM6j-ue2tSFEpHh527bY130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408184.RA-B-CVJdvz9q6ojR6bX7qSXHTM6j-ue2tSFEpHh527bY130_provenance.
• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149252.RA5fIlN-P2SFbG2fgF3BmUVjx5upWvDJWbQhe4HELaWqg130_provenance.
• NP1149253.RAyLGYMCGk5iPhFho6Cc8f7rcELP3bYeJx8fDAPm0n_ug130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149253.RAyLGYMCGk5iPhFho6Cc8f7rcELP3bYeJx8fDAPm0n_ug130_provenance.
• NP1149254.RA57MJV9eUCk8Ul2cdbzgHHM_QahrrDd4UgmYVzwXEG5M130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149254.RA57MJV9eUCk8Ul2cdbzgHHM_QahrrDd4UgmYVzwXEG5M130_provenance.
• NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149255.RA-bigh8kJ3a8UKyOmHbW98NuySybp4DB4DFYRUK_9Hvw130_provenance.
• NP219669.RAEB25Lqp3PahSdb_-BzNQwTJEGnFQIXRRodRcLrPkiNQ130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219669.RAEB25Lqp3PahSdb_-BzNQwTJEGnFQIXRRodRcLrPkiNQ130_provenance.
• NP577148.RAL457h_w2X4yhSyhaUdgEQavSPZhomHgoXjEr-xX_nb4130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577148.RAL457h_w2X4yhSyhaUdgEQavSPZhomHgoXjEr-xX_nb4130_provenance.
• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP219145.RAqnCGNsVUSRsHtktdKAE0pJd5Ib9xURNfSV6mmNoTw3E130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219145.RAqnCGNsVUSRsHtktdKAE0pJd5Ib9xURNfSV6mmNoTw3E130_provenance.
• NP1149251.RAKDOVi8CTeufnnJZgvynkRfuOUR5RMKZoCfLyBV2yOvY130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149251.RAKDOVi8CTeufnnJZgvynkRfuOUR5RMKZoCfLyBV2yOvY130_provenance.
• NP1149258.RAtoARvSmL9dLZFtW6g5fTk2EJZBXeL5cZQ13lZrxLV2c130_assertion description "[The incorporation of ABL kinase inhibitors into acute lymphoblastic leukemia management should serve as a model for incorporation of FLT3-targeted agents into clinical care.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1149258.RAtoARvSmL9dLZFtW6g5fTk2EJZBXeL5cZQ13lZrxLV2c130_provenance.